Write a short note on post-exposure prophylaxis for HIV.
Definition
Post-exposure prophylaxis is the short-term administration of antiretroviral drugs after a potential exposure to HIV, to reduce the risk of establishing infection. Its rationale is that HIV requires 24–72 hours to establish systemic infection after mucosal or parenteral exposure, providing a window in which drugs can prevent seroconversion.
Risk of Transmission Per Exposure
| Exposure | Approximate risk |
|---|---|
| Blood transfusion (infected unit) | ~90–95% |
| Needle sharing (injecting drug use) | ~0.67% |
| Percutaneous needlestick injury | ~0.3% |
| Mucous membrane splash | ~0.09% |
| Receptive anal intercourse | ~1.4% |
| Receptive vaginal intercourse | ~0.08% |
| Intact skin contact | Negligible |
Factors increasing risk: deep injury, visibly bloodstained device, hollow-bore needle (which retains more blood than a suture needle), a device previously in the source's artery or vein, high source viral load (untreated or acute infection), and a large volume of blood.
Indications
- Occupational: needlestick or sharps injury, mucous membrane or non-intact skin exposure to blood or high-risk body fluid in healthcare workers, laboratory staff and waste handlers.
- Non-occupational: sexual assault, unprotected intercourse with a person of known or high-risk HIV status, condom failure, sharing of injecting equipment, and needlestick injury in the community.
High-risk fluids: blood, semen, vaginal and cervical secretions, breast milk, CSF, synovial, pleural, pericardial, peritoneal and amniotic fluid, and any fluid visibly contaminated with blood.
Low or no risk: urine, faeces, saliva, sweat, tears, vomit and nasal secretions — unless visibly bloodstained.
Immediate Management of the Exposure
1. First aid — immediately:
- Wash the wound with soap and running water; allow it to bleed freely. Do NOT squeeze, scrub, or apply caustic agents, antiseptics such as bleach, or attempt to suck the wound — these damage tissue and may increase uptake.
- Irrigate mucous membranes and eyes copiously with water or saline (remove contact lenses first, then irrigate).
2. Report immediately to the designated officer or casualty; do not delay to complete paperwork.
3. Assess the exposure — the type of injury, the device, the fluid, and the depth.
4. Test the source where possible, with consent and counselling — a negative source test allows PEP to be stopped.
5. Baseline testing of the exposed person: HIV, hepatitis B surface antigen and antibody status, hepatitis C, and a pregnancy test where relevant.
Pep Regimen and Timing
- Start as soon as possible — ideally within 2 hours, and certainly within 72 hours. Efficacy falls sharply with delay, and PEP is not recommended beyond 72 hours.
- Do not wait for source testing to start the first dose — begin, and stop later if the source proves negative.
- Duration: 28 days of a three-drug regimen, using the same well-tolerated combinations as first-line treatment (a tenofovir/lamivudine backbone with an integrase inhibitor such as dolutegravir).
- Counselling on adherence, side effects (nausea, fatigue, headache — common and a frequent cause of discontinuation), and safe practices during the follow-up period.
Follow-up
- HIV testing at baseline, 6 weeks, 3 months and 6 months (schedules vary; fourth-generation assays allow shorter follow-up).
- Monitor for drug toxicity — CBC, renal and liver function during the course.
- Advise on preventing secondary transmission for at least 3 months — use condoms, avoid donating blood, semen or organs, and avoid breastfeeding where an alternative is safe.
- Hepatitis B prophylaxis — vaccination with or without hepatitis B immunoglobulin depending on the exposed person's immune status; hepatitis C requires no prophylaxis but does require follow-up testing, with early treatment if seroconversion occurs.
- Psychological support — the anxiety following an exposure is considerable and often under-addressed, particularly after sexual assault; provide counselling and, where relevant, emergency contraception, STI prophylaxis and medico-legal support.
Prevention of Exposure — the Real Solution
Universal (standard) precautions applied to every patient regardless of known status: gloves and protective equipment, safe handling and disposal of sharps in puncture-proof containers, NEVER recapping needles, use of safety-engineered devices, hand hygiene, safe waste segregation, and hepatitis B vaccination of all healthcare workers.
The single most important determinant of PEP efficacy is TIME. Start within hours — the first dose can be given from a starter pack before any counselling, testing or paperwork is completed. Two common and costly errors are waiting for the source patient's result before starting, and failing to complete the full 28 days because of nausea. Neither is acceptable; give an antiemetic and support adherence.
The recommended PEP drug regimen and follow-up testing schedule — confirm against current NACO guidance before printing.
All questions in HIV and AIDS
- Q1Discuss the aetiology, transmission, natural history, clinical features, diagnosis and staging of HIV infection. ★
- Q2Discuss the opportunistic infections in HIV in relation to CD4 count, including the CNS complications of AIDS. ★
- Q3Discuss antiretroviral therapy — classes of drugs, first-line regimens, adverse effects, monitoring and treatment failure. ★
- SN1Write a short note on post-exposure prophylaxis for HIV.
- SN2Write a short note on immune reconstitution inflammatory syndrome.
- SN3Write a short note on acute HIV (primary) infection.